The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice

Journal of Clinical Investigation

Volumn 100, Issue 6, 1997, Pages 1575-1580

  Daugherty, Alan ^a,d   Puré, Ellen ^b   Delfel Butteiger, Dustie ^a   Chen, Sam ^b   Leferovich, John ^c   Roselaar, Simon E ^a   Rader, Daniel J ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cell mediated immunity; Humoral immunity

Indexed keywords

APOLIPOPROTEIN E; AUTOANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030771822     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119681     Document Type: Article

References (57)

1. Shi, C.W., W.S. Lee, Q. He, D. Zhang, D.L. Fletcher, J.B. Newell, and E. Haber. 1996. Immunologic basis of transplant-associated arteriosclerosis. Proc. Natl. Acad. Sci. USA. 93:4051-1056.
2. Hansson, G.K., J. Holm, S. Holm, Z. Fotev, H.J. Hedrich, and J. Fingerle. 1991. Lymphocytes-T inhibit the vascular response to injury. Proc. Natl. Acad. Sci. USA. 88:10530-10534.
3. Hansson, G.K., and J. Holm. 1991. Interferon-γ inhibits arterial stenosis after injury. Circulation. 84:1266-1272.
4. Libby, P., and G.K. Hansson. 1991. Involvement of the immune system in human atherogenesis - current knowledge and unanswered questions. Lab. Invest. 64:5-15.
5. Emeson, E.E., and A.L. Robertson, Jr. 1988. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am. J. Pathol. 130:369-376.
6. Shimokama, T., S. Haraoka, and T. Watanabe. 1991. Immunohistochemical and ultrastructural demonstration of the lymphocyte-macrophage interaction in human aortic intima. Mod. Pathol. 4:101-107.
7. Jonasson, L., J. Holm, O. Skalli, G. Bondjers, and G.K. Hansson. 1986. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:131-138.
8. Hansson, G.K., L. Jonasson, B. Lojsthed, S. Stemme, O. Kocher, and G. Gabbiani. 1988. Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis. 72:135-141.
9. Stemme, S., L. Rymo, and G.K. Hansson. 1991. Polyclonal origin of lymphocyles-T in human atherosclerotic plaques. Lab. Invest. 65:654-660.
10. Swanson, S.J., A. Rosenzweig, J.G. Seidman, and P. Libby. 1994. Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. Arterioscler. Thromb. 14:1210-1214.
11. Hansson, G.K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169-175.
12. van der Wal, A.C., K.P. Dingemans, M. van den Bergh Weerman, P.K. Das, and A.E. Becker, 1994. Specialized membrane contacts between immunocompentent cells in human atherosclerotic plaques. Cardiovasc. Pathol. 3:81-85.
13. Kishikawa, H., T. Shimokama, and T. Watanabe. 1993. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Arch. A. Pathol. Anat. 423:433-442.
14. Rolfe, B.E., J.H. Campbell, N.J. Smith, M.W. Cheong, and G.R. Campbell. 1995. T lymphocytes affect smooth muscle cell phenotype and proliferation. Arterioscler. Thromb. Vasc. Biol. 15:1204-1210.
15. Xu, Q., J. Willeit, M. Marosi, R. Kleindienst, F. Oberhollenzer, S. Kiechl, T. Stulnig, G. Luef, and G. Wick. 1993. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet (N. Am. Ed.) 341: 255-259.
16. Salonen, J.T., S. Yla-Herttuala, R. Yamamoto, S. Butler, H. Korpela, R. Salonen, K. Nyyssonen, W. Palinski, and J.L. Witztum. 1992. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet (N. Am. Ed.) 339:883-887.
17. Kiener, P.A., B.M. Rankin, P.M. Davis, S.A. Yocum, G.A. Warr, and R.I. Grove. 1995. Immune complexes of LDL induce atherogenic responses in human monocytic cells. Arterioscler. Thromb. Vasc. Biol. 15:990-999.
18. Ylä-Herttuala, S., W. Palinski, S.W. Butler, S. Picard, D. Steinberg, and J.L. Witztum. 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14:32-40.
19. Emeson, E.E., and M.L. Shen. 1993. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin-A. Am. J. Pathol. 142: 1906-1915.
20. Roselaar, S.E., G. Schonfeld, and A. Daugherty. 1995. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J. Clin. Invest. 96:1389-1394.
21. Drew, A.F., and P.G. Tipping. 1995. Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis. 116:181-189.
22. Emeson, E.E., M.L. Shen, C.G.H. Bell, and A. Qureshi. 1996. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am. J. Pathol. 149:675-685.
23. Fyfe, A.I., J.H. Qiao, and A.J. Lusis. 1994. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J. Clin. Invest. 94:2516-2520.
24. Qiao, J.H., P.Z. Xie, M.C. Fishbein, J. Kreuzer, T.A. Drake, L.L. Demer, and A.J. Lusis. 1994. Pathology of atheromatous lesions in inbred and genetically engineered mice - genetic determination of arterial calcification. Arterioscler. Thromb. 14:1480-1497.
25. Roselaar, S.E., P.X. Kakkanathu, and A. Daugherty. 1996. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/-mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol. 16:1013-1018.
26. Zhou, X.H., S. Stemme, and G.K. Hansson. 1996. Evidence for a local immune response in atherosclerosis: CD4(+) T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am. J. Pathol. 149:359-366.
27. Palinski, W., V.A. Ord, A.S. Plump, J.L. Breslow, D. Steinberg, and J.L. Witztum. 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis - demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14:605-616.
28. Nakashima, Y., A.S. Plump, E.W. Raines, J.L. Breslow, and R. Ross. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133-140.
29. Reddick, R.L., S.H. Zhang, and N. Maeda. 1994. Atherosclerosis in mice lacking apoE - Evaluation of lesional development and progression. Arterioscler. Thromb. 14:141-147.
30. Breslow, J.L. 1996. Mouse models of atherosclerosis. Science (Wash. DC). 272:685-688.
31. Lichtman, A.H., M. Cybulsky, and F.W. Luscinskas. 1996. Immunology of atherosclerosis: the promise of mouse models. Am. J. Pathol. 149:351-357.
32. Shinkai, Y., G. Rathbun, K.-P. Lam, E.M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A.M. Stall, and F.W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:855-867.
33. Piedrahita, J.A., S.H. Zhang, J.R. Hagaman, P.M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein-E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:4471-4475.
34. Kung, J.T., S.O. Sharrow, D.G. Sieckmann, R. Lieberman, and W.E. Paul. 1981. A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody. J. Immunol. 127:873-876.
35. Leo, O., D.H. Foo, L.E. Sachs, L.E. Samelson, and J.A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide Proc. Natl. Acad. Sci. USA. 84:1374-1378.
36. Cole, T.G., R. Kitchens, A. Daugherty, and G. Schonfeld. 1990. An improved method for separation of triglyceride-rich lipoproteins by FPLC. Pharmacia Biocommunique. 4:4-6.
37. Haberland, M.E., A.M. Fogelman, and P.A. Edwards. 1982. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc. Natl. Acad. Sci. USA. 79:1712-1716.
38. Ishikawa, T.T., J. MacGee, J.A. Morrison, and C.J. Glueck. 1974. Quantitative analysis of cholesterol in 5 and 20 μl of plasma. J. Lipid Res. 15:286-291.
39. Daugherty, A., B.S. Zweifel, and G. Schonfeld. 1991. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits. Br. J. Pharmacol. 103:1013-1018.
40. Daugherty, A., and S.E. Roselaar. 1995. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovasc. Res. 29:297-311.
41. Bligh, E.G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and characterization. Can. J. Physiol. Pharmacol. 37:911-916.
42. Plump, A.S., J.D. Smith, T. Hayek, K. Aaltosetala, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
43. Zhang, S.H., R.L. Reddick, J.A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (Wash. DC). 258:468-171.
44. Paigen, B., A. Morrow, P. Holmes, D. Mitchell, and R. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68: 231-240.
45. Tangirala, R.K., E.M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36:2320-2328.
46. Daugherty, A., B.S. Zweifel, and G. Schonfeld. 1989. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br. J. Pharmacol. 98:612-618.
47. Palinski, W., R.K. Tangirala, E. Miller, S.G. Young, and J.L. Witztum. 1995. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15:1569-1576.
48. Palinski, W., E. Miller, and J.L. Witztum. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad Sci. USA. 92:821-825.
49. Brand, K., N. Mackman, and L.K. Curtiss. 1993. Interferon-γ inhibits macrophage apolipoprotein-E production by posttranslational mechanisms. J. Clin. Invest. 91:2031-2039.
50. Fong, L.G., T.S.E. Albert, and S.E. Horn. 1994. Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-γ. J. Lipid Res. 35:893-904.
51. Fong, L.G., T.A.T. Fong, and A.D. Cooper. 1990. Inhibition of mouse macrophage degradation of acetyl low density lipoprotein by interferon-γ. J. Biol. Chem. 265:11751-11760.
52. Geng, Y.J., and G.K. Hansson. 1992. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89:1322-1330.
53. de Villiers, W.J.S., I.P. Fraser, and S. Gordon. 1994. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol. Lett. 43:73-79.
54. LaMarre, J., B.B. Wolf, E.L.W. Kittler, P.J. Quesenberry, and S.L. Gomas. 1993. Regulation of macrophage α2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-γ. J. Clin. Invest. 91:1219-1224.
55. Steeg, P.S., R.N. Moore, H.M. Johnson, and J.J. Oppenheim. 1982. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J. Exp. Med. 156:1780-1793.
56. Stuart, P.M., A. Zlotnik, and J.G. Woodward. 1988. Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1). J. Immunol. 140:1542-1547.
57. Dansky, H.M., S.A. Charlton, M.M. Harper, and J.D Smith. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 94:4642-4646.